消费者对减处方态度的系统综述与荟萃分析
该研究检索2013年1月至2020年3月数据库,汇总使用PATD及其修订版问卷的原始研究,纳入46篇文章、40项研究共10816名参与者。荟萃分析显示,84%(95%CI 81%-88%)的患者和80%(95%CI 74%-86%)的照护者愿意在医生建议下停用一种或多种药物,但异质性显著。
要点
- 患者与照护者多数表示愿意在医生建议下减停药物。
- 合并比例异质性高(I2分别为95%和77%),解读需谨慎。
- 结果可推动临床开展减处方讨论并采纳相关建议。
核心结论
- 消费者报告愿意接受减处方,但因异质性结果应谨慎解读,研究有助于理解减处方态度并促进临床讨论与建议采纳。
研究设计与样本
- 系统综述与荟萃分析,检索2013年1月至2020年3月数据库,并用Google Scholar追踪PATD开发与验证文稿的引用以识别原始研究。
- 纳入46篇文章描述40项研究,共10816名参与者,使用经验证的PATD、修订版PATD(老年人版与照护者版)及认知障碍版rPATDcog。
- 由两名作者独立提取数据,采用随机效应模型进行比例荟萃分析,并按设置和人群做亚组荟萃分析。
主要发现
- 主要结局为对「如果我的医生说可以,我愿意停用一种或多种药物」的同意或强烈同意比例。
- 患者的同意或强烈同意比例为84%(95%CI 81%-88%),照护者为80%(95%CI 74%-86%)。
- 异质性显著,患者I2=95%,照护者I2=77%。
- 次要结局包括参与者特征与主要结局的关联及其他(r)PATD结果。
关键数值与推荐
- 患者愿意减停一种或多种药物的合并比例为84%(95%CI 81%-88%)。
- 照护者愿意减停一种或多种药物的合并比例为80%(95%CI 74%-86%)。
临床怎么用
- 在老年患者用药审核中可主动提出减处方讨论,因多数患者和照护者报告愿意在医生建议下停用药物。
- 沟通时应结合个体情况谨慎解读意愿比例,注意研究间高异质性。
局限性
- 合并结果异质性显著(患者I2=95%,照护者I2=77%),结果应谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Harmful and/or unnecessary medication use in older adults is common. This indicates deprescribing (supervised withdrawal of inappropriate medicines) is not happening as often as it should. This study aimed to synthesize the results of the Patients' Attitudes Towards Deprescribing (PATD) questionnaire (and revised versions). METHODS: Databases were searched from January 2013 to March 2020. Google Scholar was used for citation searching of the development and validation manuscripts to identify original research using the validated PATD, revised PATD (older adult and caregiver versions), and the version for people with cognitive impairment (rPATDcog). Two authors extracted data independently. A meta-analysis of proportions (random-effects model) was conducted with subgroup meta-analyses for setting and population. The primary outcome was the question: "If my doctor said it was possible, I would be willing to stop one or more of my medicines." Secondary outcomes were associations between participant characteristics and primary outcome and other (r)PATD results. RESULTS: We included 46 articles describing 40 studies (n = 10,816 participants). The meta-analysis found the proportion of participants who agreed or strongly agreed with this statement was 84% (95% CI 81%-88%) and 80% (95% CI 74%-86%) in patients and caregivers, respectively, with significant heterogeneity (I2 = 95% and 77%). CONCLUSION: Consumers reported willingness to have a medication deprescribed although results should be interpreted with caution due to heterogeneity. The findings from this study moves toward understanding attitudes toward deprescribing, which could increase the discussion and uptake of deprescribing recommendations in clinical practice.
引用
- Weir KR, Ailabouni NJ, Schneider CR, et al. Consumer Attitudes Towards Deprescribing: A Systematic Review and Meta-Analysis. J Gerontol A Biol Sci Med Sci. 2022. PMID: 34390339. doi:10.1093/gerona/glab222
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。